Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Zinc oxide 283.5mg / Lidocaine 13.2mg suppositories |
BNF code | 0107010N0AAAGAG |
Virtual Therapeutic Moiety | Zinc oxide + Lidocaine |
Basis of preferred name | Other |
Date of name applicability | 1 Dec 2003 |
Previous name | Zinc oxide 283.5mg / Lignocaine 13.2mg suppositories |
Basis of previous name | Other |
Reason for name change | Basis of name changed |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | suppository |
Unit dose unit of measure | suppository |
Virtual Product Ingredient | |
---|---|
Ingredient | Zinc oxide |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 283.500 |
Strength value numerator unit | mg |
Virtual Product Ingredient | |
Ingredient | Lidocaine hydrochloride |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 13.200 |
Strength value numerator unit | mg |
Ontology Drug Form & Route | |
Form & Route | suppository.rectal |
Dose Form | |
Formulation | Suppository |
Drug Route | |
Route | Rectal |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Germoloids suppositories (Bayer Plc) | |
Virtual Medicinal Product Packs | |
Zinc oxide 283.5mg / Lidocaine 13.2mg suppositories 12 suppository | |
Zinc oxide 283.5mg / Lidocaine 13.2mg suppositories 24 suppository |
dm+d data retrieved from TRUD: release NHSBSA_11.3.0_20241125000001, imported on 26th November 2024 at 03:54:16.